Alphatec Holdings Inc (ATEC)

Currency in USD
19.80
+0.29(+1.49%)
Closed·
20.24+0.44(+2.22%)
·
ATEC Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Trading near 52-week High
ATEC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.4920.17
52 wk Range
8.1820.17
Key Statistics
Prev. Close
19.51
Open
19.62
Day's Range
19.49-20.17
52 wk Range
8.18-20.17
Volume
2.36M
Average Volume (3m)
2.23M
1-Year Change
110.64%
Book Value / Share
0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATEC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
21.38
Upside
+7.95%
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Alphatec Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Alphatec Holdings Inc Company Profile

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Alphatec Holdings Inc Earnings Call Summary for Q3/2025

  • Alphatec's Q3 2025 revenue surged 30% YoY to $197M, with EPS of $0.03 significantly outperforming the expected -$0.04 loss, triggering a 1.21% stock increase in aftermarket trading.
  • The company reported strong surgical revenue of $177M (+31% YoY) and EOS revenue of $20M (+29% YoY), while generating positive free cash flow of $5M and maintaining $260M in available cash.
  • Management raised full-year revenue guidance to $760M and set ambitious targets of $1B revenue by 2027, with 18% adjusted EBITDA and $65M in free cash flow.
  • CEO Pat Miles emphasized creating 'clinical distinction' to drive surgeon adoption, with the upcoming Valence navigation system expected to further accelerate growth in the spine surgery market.
Last Updated: 30/10/2025, 22:52
Read Full Transcript

Compare ATEC to Peers and Sector

Metrics to compare
ATEC
Peers
Sector
Relationship
P/E Ratio
−19.0x3.8x−0.6x
PEG Ratio
−1.080.310.00
Price/Book
255.6x4.3x2.6x
Price / LTM Sales
4.0x4.4x3.3x
Upside (Analyst Target)
21.2%57.1%44.9%
Fair Value Upside
Unlock5.6%5.8%Unlock

Analyst Ratings

11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 21.38
(+7.95% Upside)

Earnings

Latest Release
Oct 30, 2025
EPS / Forecast
0.03 / -0.04
Revenue / Forecast
196.50M / 182.77M
EPS Revisions
Last 90 days

ATEC Income Statement

People Also Watch

239.48
SNDK
+15.31%
10.78
CRML
+7.05%
162.96
WDC
-0.39%
5.37
NUAI
-11.09%
62.380
IREN
-6.84%

FAQ

What Is the Alphatecs (ATEC) Premarket Price Today?

The Alphatecs (ATEC) premarket price is 19.38. Premarket price change units: -0.13. Premarket percentage change: -0.67%. Premarket volume: 4,980.00. Current date: 10 Nov 2025. Previous close: 19.51

What Stock Exchange Does Alphatecs Trade On?

Alphatecs is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Alphatecs?

The stock symbol for Alphatecs is "ATEC."

What Is the Alphatecs (ATEC) Afterhours Price Today? (Afterhours variable test: 20.24) Current Date: 10 Nov 2025

After hours price: 20.24. After hours price change (units): 0.44. Price change percentage: 2.22%

What Is the Alphatecs Market Cap?

As of today, Alphatecs market cap is 2.94B.

What Is Alphatecs's Earnings Per Share (TTM)?

The Alphatecs EPS (TTM) is -1.05.

When Is the Next Alphatecs Earnings Date?

Alphatecs will release its next earnings report on 02 Mar 2026.

From a Technical Analysis Perspective, Is ATEC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Alphatecs Stock Split?

Alphatecs has split 1 times.

How Many Employees Does Alphatecs Have?

Alphatecs has 867 employees.

What is the current trading status of Alphatecs (ATEC)?

As of 10 Nov 2025, Alphatecs (ATEC) is trading at a price of 19.80, with a previous close of 19.51. The stock has fluctuated within a day range of 19.49 to 20.17, while its 52-week range spans from 8.18 to 20.17.

What Is the ATEC Premarket Price?

ATEC's last pre-market stock price is 19.38. The pre-market share volume is 4,980.00, and the stock has decreased by -0.13, or -0.67%.

What Is the ATEC After Hours Price?

ATEC's last after hours stock price is 20.24, the stock has decreased by 0.44, or 2.22%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.